Today, Dr. Gould and his patient, Dave, were guests during FM News Talk 97.1’s EYE ON HEALTH! During the hour long radio show, host Dr. Michael Jones asked Dr. Gould about sinusitis and the cutting edge treatment, In-Office Balloon Sinus Dilation. Dave underwent Balloon Sinus Dilation two years ago and today he shared his experience …
Dr. Gould Was Today’s Guest on FM News Talk 97.1’s EYE ON HEALTH! Read More »
Dr. Gould – Guest Sinus Expert on KMOV Channel 4’s Great Day St. Louis! Dr. Gould discussed In-Office Balloon Sinus Dilation, which is the groundbreaking procedure that is changing the way sinusitis it treated. If you suffer from recurrent or chronic sinusitis, this proven Balloon Sinus Dilation could end your cycle of infections for good! …
Dr. Gould – Guest Sinus Expert on KMOV Channel 4’s Great Day St. Louis! Read More »
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System Entellus Medical, Inc. 3 hours ago GlobeNewswire PLYMOUTH, Minn., Feb. 13, 2015 (GLOBE NEWSWIRE) — Entellus Medical, Inc. (ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating …
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System Read More »
Dr. Gould Performs An In-Office Balloon Sinus Dilation Procedure While Streaming LIVE to the World! Entellus Medial is the manufacturer of XprESSTM Multi-Sinus Dilation System, the device used for In-Office Balloon Sinus Dilation. In 2014, Entellus Medical launched an exciting educational series designed to connect surgeons with peers who are performing In-Office Balloon Sinus Dilation. As a …
Dr. Gould was invited to Entellus Medical’s National Sales Meeting in San Diego California February 5th-8th. Dr. Gould will participate in a panel discussion on emerging technologies in the field of balloon sinus dilation to educate and discuss cutting-edge technologies by Entellus Medical, Inc.
PLYMOUTH, Minn., Feb. 3, 2015 (GLOBE NEWSWIRE) — Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, announced today the closing of its initial public offering of 5,294,117 shares of its common stock (including 690,537 shares purchased by …
Entellus Medical, Inc. Announces Pricing of Initial Public Offering (Feb 3, 2015) Read More »
Please include non-medical questions and correspondence only.
